Table 3.
Change in MD, baseline to 12-month follow-up
| Placebo (n = 21) | Atorvastatin (n = 23) | ||
|---|---|---|---|
| BIRAD category | N (%) | N (%) | P value |
| No change | 14 (58%) | 16 (70%) | |
| Increase | 1 (4%) | 3 (13%) | 0.244 |
| Decrease | 6 (25%) | 4 (17%) | |
| Placebo (n = 20) | Atorvastatin (n = 20) | ||
| VAS | Mean change (95% CI) | Mean change (95% CI) | |
| −0.3 (−3.8–3.2) | 0 (−3.9–3.9) | 0.9056 | |